2013, Number 1
<< Back Next >>
salud publica mex 2013; 55 (1)
Genomic medicine in public health policies: a perspective of Mexican biomedical researchers.
Oliva-Sánchez PF, Siqueiros-García JM, Vázquez-González JR, Saruwatari-Zavala G, Carnevale A
Language: Spanish
References: 24
Page: 16-25
PDF size: 237.84 Kb.
ABSTRACT
Objective. The purpose of this study was to explore the
researcher’s perspectives on genomic medicine (GM) and
its consequences in the decision-making process regarding
the health policy in Mexico.
Materials and methods.
An exploratory qualitative research was conducted (semistructured
questionnaire). The study was conducted during
the II National Congress of GM (25 - 27th October 2006).
Results. We identified four categories amongst the researcher’s
perspectives regarding the applicability of GM
and the political feasibility of the genomics research. Some
researchers believe that the 3P’s of GM (Predictive, Personalized,
Preventive) have generated “inflated expectations” on
the real impact on public health (PH). Opinions were divided
among those who believed that GM is the new ‘paradigm’ of
PH and those who thought that GM is part of a set of tools
for PH.
Conclusion. To improve the health conditions of
the Mexican population, GM must be part in the solution of
the PH problems, but we need a realistic view.
REFERENCES
Collins FS. Schattuck Lecture – Medical and societal consequences of the Human Genome Project. N Engl J Med 1999; 341(1): 28-37.
Collins FS, Green ED, Guttmacher E, Guyer MS. A vision for the future of genomics research. A blueprint for the genomic era. Nature 2003;422:835-847.
Jimenez-Sanchez G. Developing a platform for genomic medicine in Mexico. Science 2003;300:295-296.
Aréchiga H, Drucker-Colín R, Jimenez-Sanchez G, Laclette JP, Lopez de Salines A, Martuscelli J, et al. El proyecto del genoma humano: perspectivas de la medicina genómica. Rev Fac Med UNAM 2000;435: 202-205.
Barrera H, Martinez-Garza S, Ortiz-Lopez R. Diagnóstico molecular de cáncer. Rev Invest Clin 2003;55:128-137.
Kershenobich D. Biología molecular en gastroenterología. Rev Invest Clin 2003;55:181-185.
Tusie-Luna MT. El camino hacía la comprensión molecular de las enfermedades. Rev Invest Clin 2003;55:143-147.
Mutchinick OM. La medicina en un contexto genético y molecular. Rev Invest Clin 2003; 55:186-190.
Lisker R. De la hipótesis de la evolución de las especies a la Genómica, pasando por la Genética. Rev Invest Clin 2003; 55:110-118.
Salamanca-Gomez F, Carnevale A, Kofman-Alfaro S, Lopez M, Torres Maldonado LC, Armendares S, et al. An update of molecular genetics in medicine. Gac Med Mex 1993;129:273-289.
Silva-Zolezzi I, Hidalgo-Miranda A, Estrada-Gil J, Fernandez-Lopez JC, Uribe-Figueroa L, Contreras A. Analysis of genomic diversity in Mexican Mestizo population to develop genomic medicine in Mexico. Proc Natl Acad Sci U S A 2009;106: 8611-8616.
Jiménez-Sánchez G. Oportunidades para la industria farmacéutica en el Instituto Nacional de Medicina Genómica de México. Gac Med Mex 2002; 1383: 291-294.
Seguin B, Essajee S, Jimenez-Sanchez G, Singer P, Daar A. Human genomic variation studies and pharmacogenomics are critical for global health. En: Suarez-Kurtz G, ed. Pharmacogenomics in ddmixed populations. Landes Bioscience 2007.
Epstein CJ. Medical genetics in the genomic medicine of the 21st century. Am J Hum Genet 2006;793:434-438.
Hanney SR, Gonzalez-Block MA, Buxton MJ, Kogan M. The utilization of health research in policy-making: concepts, examples and methods of assessment. Health Research Policy and Systems, 2003. [consultado 2011 agosto 26] Disponible en: http://www.health-policy-systems.com/ content/1/1/2.
Reich MR, Public-private partnerships for public health. Nature Medicine 2000;6:617-620.
Ruiz-Ruiz J. Análisis sociológico del discurso: métodos y lógicas. Forum Qualitative Sozialforschung / Forum: Qualitative Social Research 10(2), Art. 26, 2009.
Oliva-Sánchez PF, Zaga-Galante J, Arellano-Méndez A, Millet-Hassey F, Rosenthal-Peretzman J, Isasi R. HumGen en español: una herramienta legislativa y política en genómica humana y salud pública. Rev Panam Salud Publica 2011;29: 475-476.
Romero-Hidalgo S, Urraca N, Parra D, Villa AR, Lisker R, Carnevale A. Attitudes and anticipated reactions to genetic testing for cancer among patients in Mexico City. Genet Test Mol Biomarkers 2009;13 :477-483.
Lisker R. Medicina genómica, mitos y realidades. Rev Invest Clin 2004; 56:554-560.
Lisker R, Carnevale A. Changing opinions of Mexican geneticists on ethical issues. Arch Med Res 2006;37:794-803.
Knoppers BM, Scriver C. Genomics, health and society: Emerging issues for public policy. En: The Policy Research Initiative. Canada, 2004
Comisión Mexicana de Macroeconomía y Salud. Macroeconomía y Salud. Invertir en salud para el desarrollo económico. México: Fondo de Cultura Económica, Colección Biblioteca de la Salud, 2006.
Evans JP, Meslin EM, Marteau TM, Caulfield F. Policy Forum: Deflating the genomic bubble. Science 2011;331:861-862.